Chemed Corp (CHE) Social Stream
CHEMED CORP (CHE) Price Targets From Analysts
Use the tables below to see what analysts covering CHEMED CORP think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CHE's average price target has moved down $29.67 over the prior 13 months.
Over the past 49 weeks, CHE's average upside potential has been 19.65%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CHE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
CHE's average broker recommendation rating worsened by 0.33 over the prior 123 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, CHEMED CORP's average analyst price target is higher than 691.03% of them.
- CHE has a lower variance in analysts' estimates than 70.98% of Healthcare stocks.
- In terms of how CHEMED CORP fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 43.82% of that group.
- CHEMED CORP's upside potential (average analyst target price relative to current price) is higher than 107.59% of Healthcare stocks.
Is CHE a Buy, Hold or Sell? See the POWR Ratings now!